Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Early diagnosis cuts Singapore TB (tuberculosis) rates:

This article was originally published in Clinica

Executive Summary

The key component of Singapore's successful TB elimination programme is early diagnosis, the results of which continue to be seen after 10 years of declining incidence. According to Singapore's health ministry, the number of cases and new incidence has declined steadily over the past decade. Between 1997 and 2006, the number of cases dropped form 1,712 to 1,256, and the rate per 100,000 of population in 2006 was 34.8, down from 54.9 in 1997 and 37 in 2005. The Singapore Tuberculosis Elimination programme (STEP) was set up in 1997 - this and concerted efforts by the medical community are said to be primarily responsible for the decline of the air-borne disease.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT047990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel